Skip to Content

Safeguard Your Intellectual Property ®

Bond Amount Increased to $62 Million for Potential Recovery by SSJR Client Apotex After Successful Budesonide Trial

SSJR has secured an additional $2 million bond from AstraZeneca, adding to an existing $60 million bond, to allow recovery of damages and costs sustained by SSJR client Apotex as a result of an injunction improvidently issued by the District Court. If the trial court’s recent decision that the AstraZeneca’s […]

Read More

April 15, 2013 by in General

SSJR Client Monsieur Touton Selection, Ltd. Awarded Attorneys’ Fees as Patent Infringement Lawsuit Dismissed With Prejudice

On April 4, 2013, the District Court for the Southern District of New York dismissed, with prejudice, a patent infringement lawsuit that had been brought against SSJR’s client Monsieur Touton Selection, Ltd. (“Touton”). Touton was sued by Lamina Packing Innovations, LLC, for infringement of two patents related to laminated cartons […]

Read More

April 4, 2013 by in General

SSJR Wins Patent Infringement Trial for Apotex Regarding Budesonide (Pulmicort® Respules)

SSJR’s trial team successfully defended its client Apotex against a claim of patent infringement brought by AstraZeneca regarding a generic version of AstraZeneca’s Pulmicort Respules. AstraZeneca filed suit against Apotex and several other generic drug manufacturers for infringement of two U.S. patents directed to methods of use and formulations of […]

Read More

April 1, 2013 by in General